Panbio, Inc.

Columbia, MD 21046
14 Employees

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $300K
First Award Date 09/01/00
Most Recent Award Date 01/27/06

Key Personnel

Last Name Name Awards Contact
Hanson Dr. Barbara Hanson 1 Message
Paxton Helene Paxton 2

3 Awards Won

Phase 1 SBIR

Agency: Office of the Secretary of Defense
Topic: OSD05-H07
Budget: 01/27/06 - 01/27/07

A new technology in infectious disease diagnostics will be examined. The test platform will utilize Panbio's patented Oligo Rapid technology, a lateral flow cassette in which analyte binding is mediated through specifi-cally engineered oligonucleotides. The cassette strips themselves will be generic so that they can be readily adapted to a varie...

Phase 1 SBIR

Agency: Department of Health & Human Services
Budget: 02/15/01 - 08/15/01

DESCRIPTION (provided by applicant): Human granulocytic ehrlichiosis (HGE) is an emerging tick-borne disease caused by an obligate intracellular bacterium in the genogroup Ehrlichia phagocytophila (EP). Human EP infections range from inapparent to fatal. Serodiagnosis, usually by IFA, is problematic due to cross reactiv...

Phase 1 SBIR

Agency: Department of Health & Human Services
Budget: 09/01/00 - 02/28/01

Dengue virus (DEN) is a flavivirus causing dengue fever, an acute febrile illness which occurs with increasingly high incidence in the tropics and subtropics worldwide. The 4 DEN serotypes and other flaviviruses commonly cocirculate in endemic regions, which together with their extensive antigenic cross reactivity confound serodiagnosis. Because...